REG - MHP SE - MHP 2026 NOTES REDEMPTION PRICE ANNOUNCEMENT

MHP SEAnnouncement

17/02/2026 13:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260217:nRSQ3743Ta&default-theme=true

RNS Number : 3743T  MHP SE  17 February 2026

17 February 2026

MHP 2026 NOTES REDEMPTION PRICE ANNOUNCEMENT

MHP, a leading international food and agricultural group with Ukrainian roots
and one of the largest poultry producers in Europe, has announced that the
conditions precedent for the conditional redemption it announced on 15 January
2026 has been satisfied. It will on 18 February 2026 redeem U.S.$218,014,000
in the aggregate principal amount outstanding of MHP Lux S.A.'s 6.95% Notes
due 2026, which will be all of the outstanding amount of such Notes on the
said date following the settlement of the tender offer announced on 15 January
2026, in accordance with the terms of the indenture dated as of 3 April 2018
(as amended and restated from time to time) governing such Notes.

The redemption price will be as follows:

 Total.................................................................................................  U.S.$223,695,989.88
 Per                                                                                                     U.S.$205,212.50
 U.S.$200,000.............................................................................
 Per                                                                                                     U.S.$1,026.06
 U.S.$1,000.................................................................................

Disclaimer

This announcement does not contain or constitute an offer of, or the
solicitation of an offer to buy securities to any person in the United States
or in any jurisdiction to whom or in which such offer or solicitation is
unlawful, and persons into whose possession this announcement comes should
inform themselves about, and observe, any such restrictions. The securities
referred to herein may not be offered or sold in the United States absent
registration under the US Securities Act of 1933, as amended (the "Securities
Act"), or another exemption from, or in a transaction not subject to, the
registration requirements of the Securities Act. Subject to certain
exceptions, the securities referred to herein may not be offered or sold in
Australia, Canada or Japan or to, or for the account or benefit of, any
national, resident or citizen of Australia, Canada or Japan. The offer and
sale of the securities referred to herein has not been and will not be
registered under the Securities Act or under the applicable securities laws of
Australia, Canada or Japan. There will be no public offer of the securities in
the United States.

This announcement is only being distributed to and is only directed at (i)
persons who are outside the United Kingdom or (ii) to investment professionals
falling within Article 19(5) of the Financial Services and Markets Act 2000
(Financial Promotion) Order 2005 (the "Order") or (iii) high net worth
entities, and other persons to whom it may lawfully be communicated, falling
within Article 49(2)(a) to (d) of the Order (all such persons together being
referred to as relevant persons). The securities are only available to, and
any invitation, offer or agreement to subscribe, purchase or otherwise acquire
such securities will be engaged in only with, relevant persons. Any person who
is not a relevant person should not act or rely on this announcement or any of
its contents.

In member states of the European Economic Area ("EEA"), this announcement is
directed only at persons who are "qualified investors" within the meaning of
Article 2(e) of Regulation (EU) 2017/1129, as amended.

Singapore Securities and Futures Act Product Classification - Solely for the
purposes of its obligations pursuant to sections 309B(1)(a) and 309B(1)(c) of
the Securities and Futures Act (Chapter 289 of Singapore) (the "SFA"), MHP has
determined, and hereby notifies all relevant persons (as defined in Section
309A of the SFA) that the Notes are "prescribed capital markets products" (as
defined in the Securities and Futures (Capital Markets Products) Regulations
2018).

This announcement is not an advertisement of securities in Ukraine, and is not
an offer or invitation to, or solicitation of, any such circulation,
distribution, placement, sale, purchase or other transfer of the securities in
the territory of Ukraine. It is not intended to be and must not be publicly
distributed in or into Ukraine.

Please address any questions or concerns to:

 Anastasiya Sobotyuk (Kyiv)                 +38 050 339 29 99
 IR Director, ESG Compliance and Reporting  a.sobotyuk@mhp.com.ua (mailto:a.sobotyuk@mhp.com.ua)

 Christakis Taoushanis (Cyprus)             +357 99 35 22 22
 Senior Independent Director                t.taoushanis@mhp.com.cy

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCTRMJTMTMBBRF



            Copyright 2019 Regulatory News Service, all rights reserved